PIRS - Pieris Pharmaceuticals' (PIRS) CEO Steve Yoder on Q2 2019 Results - Earnings Call Transcript
Pieris Pharmaceuticals, Inc. (PIRS)
Q2 2019 Results Conference Call
August 1, 2019 8:00 AM ET
Company Participants
Allan Reine – Chief Financial Officer
Steve Yoder – President and Chief Executive Officer
Lou Matis – Senior Vice President and Chief Development Officer
Conference Call Participants
Jonathan Miller – Evercore ISI
Biren Amin – Jefferies
Matthew Phipps – William Blair
Joe Pantginis – H.C. Wainwright
Pam Barendt – Cowen
Presentation
Operator
Good morning and welcome to the Pieris Pharmaceuticals Second Quarter 2019 Conference Call. At this time all participants are in a listen-only mode. A brief question-and-answer